<DOC>
	<DOCNO>NCT00717860</DOCNO>
	<brief_summary>The purpose study investigate safety efficacy MK0991 patient deep-seated mycoses .</brief_summary>
	<brief_title>A Clinical Study MK0991 ( Caspofungin ) Japanese Patients With Deep-seated Candida Aspergillus Infections ( 0991-062 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Caspofungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<mesh_term>Micafungin</mesh_term>
	<criteria>Japanese Patients In Whom A Causative Fungus Is Detected Before Treatment With The Study Drug Or Patients With Strongly Suspected DeepSeated Fungal Infection Due To Candida specie ( Spp . ) Or Aspergillus Spp . Patients With Mycoses Other Than Ones Due To Candida Spp . Or Aspergillus Spp . Patients Who Will Receive Other Systemic Antifungal Agents For The First Time In Screening Period .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>